Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
2000
Effect of Beta Blockers, Particularly Carvedilol, on Reducing the Risk of Events After Acute Myocardial Infarction
2006
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Parkinson's disease
2021 Standout
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma
2004
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Elaboración de directrices para la publicación de investigación biomédica: proceso y fundamento científico
2005
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect
2016 Standout
Subsequent publication of abstracts presented at the International Association of Paediatric Dentistry meetings
2008
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
2010
European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
2007
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
β-adrenoreceptors and the risk of Parkinson's disease
2020
Mortality Risk Reduction Associated With Smoking Cessation in Patients With Coronary Heart Disease
2003
Search and selection methodology of systematic reviews in orthodontics (2000-2004)
2006
β-Blockers Are Associated With Reduced Risk of Myocardial Infarction After Cocaine Use
2007
The development of allergic inflammation
2008 StandoutNature
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
2005
Fish Intake, Contaminants, and Human Health
2006 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Atenolol in hypertension: is it a wise choice?
2004
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey
2002
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Management of acute myocardial infarction in patients presenting with ST-segment elevation
2003
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
2008
Periodontal diseases
2005 Standout
Effectiveness of mechanical nonsurgical pocket therapy
2005
A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease
2008
La pharmacopée de prévention cardiovasculaire est-elle sous-utilisée chez les patients souffrant d’insuffisance rénale chronique après un infarctus du myocarde ?
2010
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: Results from the American College of Cardiology’s NCDR®
2011
How should meta‐regression analyses be undertaken and interpreted?
2002 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Deciduous-dentition malocclusion predicts orthodontic treatment needs later: Findings from a population-based birth cohort study
2015
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Health outcomes of bereavement
2007 Standout
Bias in Clinical Intervention Research
2006
Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction
2006
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status
2003
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis
2002
Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010
2007
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The health impact of health care on families: a matched cohort study of hospice use by decedents and mortality outcomes in surviving, widowed spouses
2003
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
Cardioselective beta-blockers for chronic obstructive pulmonary disease
2005
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
2009
Principles for National and Regional Guidelines on Cardiovascular Disease Prevention
2004
Full publication of results initially presented in abstracts
2007 Standout
Multilevel models for meta-analysis, and their application to absolute risk differences
2001
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Harmonizing the Metabolic Syndrome
2009 Standout
ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
2005
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
2008
The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population
2007
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
2005
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
2001
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Jayne Harrison being referenced
Orthodontic treatment for posterior crossbites
2001
beta Blockade after myocardial infarction: systematic review and meta regression analysis
1999
Delay and failure to publish dental research
2005
How to … find the evidence
2003
Clinical trials in orthodontics II: assessment of the quality of reporting of clinical trials published in three orthodontic journals between 1989 and 1998
2003
The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2‐ and histamine‐induced bronchoconstriction in asthma, and relationship to plasma drug concentrations.
1992
Orthodontic treatment for posterior crossbites
2014